Technical Analysis for GMED - Globus Medical, Inc.

Grade Last Price % Change Price Change
F 51.65 0.49% 0.25
GMED closed up 0.49 percent on Monday, March 18, 2024, on 1.44 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Gapped Up Strength 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish 0.49%
Calm After Storm Range Contraction 0.49%
Doji - Bullish? Reversal 0.49%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 11 hours ago
2x Volume Pace about 12 hours ago
1.5x Volume Pace about 12 hours ago
Gapped Up (Full) about 12 hours ago
Rose Above Previous Day's High about 12 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Globus Medical, Inc. Description

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of products that promote healing in patients with spine disorders. It offers approximately 100 innovative fusion and disruptive technology products that address an array of spinal pathologies, anatomies, and surgical approaches. The company's innovative fusion products are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Its disruptive technology products provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies. The company's products under clinical development include SECURE-C Cervical Artificial Disc, an artificial disc designed to alleviate pain and preserve motion in patients with symptomatic cervical disc disease; ACADIA Facet Replacement System, which allows for an anatomic reconstruction of the facet joint after the degenerated facet is decompressed and removed; and TRIUMPH Lumbar Disc that is used in the treatment of lumbar degenerative disc disease. Globus Medical, Inc. sells its implants and related disposables primarily to hospitals. The company markets and sells its products through sales representatives and independent distributors in the United States and 17 countries internationally. Globus Medical, Inc. was founded in 2003 and is based in Audubon, Pennsylvania.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Pain Organ Systems Clinical Development Tumor Technology Products Spine Neurosurgery Healing Biomaterial Deformity Degenerative Disc Disease Fusion Products Neurosurgical Procedures Spine Disorders Vertebra

Is GMED a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 62.88
52 Week Low 43.385
Average Volume 1,174,374
200-Day Moving Average 53.29
50-Day Moving Average 54.08
20-Day Moving Average 54.49
10-Day Moving Average 53.86
Average True Range 1.66
RSI (14) 38.27
ADX 18.53
+DI 18.55
-DI 24.17
Chandelier Exit (Long, 3 ATRs) 52.41
Chandelier Exit (Short, 3 ATRs) 56.00
Upper Bollinger Bands 57.26
Lower Bollinger Band 51.72
Percent B (%b) -0.01
BandWidth 10.17
MACD Line -0.27
MACD Signal Line 0.16
MACD Histogram -0.4349
Fundamentals Value
Market Cap 5.96 Billion
Num Shares 115 Million
EPS 1.47
Price-to-Earnings (P/E) Ratio 35.14
Price-to-Sales 5.90
Price-to-Book 1.72
PEG Ratio 1.80
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 54.65
Resistance 3 (R3) 54.96 54.27 54.15
Resistance 2 (R2) 54.27 53.51 54.12 53.98
Resistance 1 (R1) 52.96 53.03 52.62 52.65 53.82
Pivot Point 52.27 52.27 52.10 52.12 52.27
Support 1 (S1) 50.96 51.51 50.62 50.65 49.48
Support 2 (S2) 50.27 51.03 50.12 49.32
Support 3 (S3) 48.96 50.27 49.15
Support 4 (S4) 48.65